Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Beglinger

Showing results (1-10 of 182) with videos related to

Pageof 19
Sort By:
Digestive Diseases (Basel, Switzerland)|July 5, 2008
Ethics related to drug therapy in the elderlyChristoph Beglinger
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2002
Overview. Cholecystokinin and eatingChristoph Beglinger
Swiss Medical Weekly|October 24, 2009
Inflammatory bowel diseaseChristoph Beglinger
Digestive Diseases (Basel, Switzerland)|September 4, 2010
Diagnosis of chronic pancreatitisChristoph Beglinger
Forum of Nutrition|December 4, 2009
Therapeutic potential of gut peptidesBettina Wölnerhanssen, Christoph Beglinger
Biochemia Medica|March 17, 2012
Faecal calprotectin in the diagnosis of inflammatory bowel diseaseEmanuel Burri, Christoph Beglinger
Expert Review of Gastroenterology & Hepatology|December 19, 2013
The use of fecal calprotectin as a biomarker in gastrointestinal diseaseEmanuel Burri, Christoph Beglinger
Nature Clinical Practice. Gastroenterology & Hepatology|January 7, 2006
Are higher doses of rifaximin more effective for the treatment of small-intestinal bacterial overgrowth?Christoph Beglinger, Lukas Degen
Swiss Medical Weekly|April 7, 2012
Faecal calprotectin -- a useful tool in the management of inflammatory bowel diseaseEmanuel Burri, Christoph Beglinger
Digestion|April 13, 2007
Helicobacter pylori and gastric cancer: the causal relationshipShajan Peter, Christoph Beglinger
Pageof 19

Showing results (1-10 of 182) with videos related to

Sort By:
Pageof 19
Digestive Diseases (Basel, Switzerland)|July 5, 2008
Ethics related to drug therapy in the elderlyChristoph Beglinger
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2002
Overview. Cholecystokinin and eatingChristoph Beglinger
Swiss Medical Weekly|October 24, 2009
Inflammatory bowel diseaseChristoph Beglinger
Digestive Diseases (Basel, Switzerland)|September 4, 2010
Diagnosis of chronic pancreatitisChristoph Beglinger
Forum of Nutrition|December 4, 2009
Therapeutic potential of gut peptidesBettina Wölnerhanssen, Christoph Beglinger
Biochemia Medica|March 17, 2012
Faecal calprotectin in the diagnosis of inflammatory bowel diseaseEmanuel Burri, Christoph Beglinger
Expert Review of Gastroenterology & Hepatology|December 19, 2013
The use of fecal calprotectin as a biomarker in gastrointestinal diseaseEmanuel Burri, Christoph Beglinger
Nature Clinical Practice. Gastroenterology & Hepatology|January 7, 2006
Are higher doses of rifaximin more effective for the treatment of small-intestinal bacterial overgrowth?Christoph Beglinger, Lukas Degen
Swiss Medical Weekly|April 7, 2012
Faecal calprotectin -- a useful tool in the management of inflammatory bowel diseaseEmanuel Burri, Christoph Beglinger
Digestion|April 13, 2007
Helicobacter pylori and gastric cancer: the causal relationshipShajan Peter, Christoph Beglinger
Pageof 19